Suivre
Kalyan C Nannuru
Kalyan C Nannuru
Adresse e-mail validée de regeneron.com
Titre
Citée par
Citée par
Année
ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A
SJ Hatsell, V Idone, DMA Wolken, L Huang, HJ Kim, L Wang, X Wen, ...
Science translational medicine 7 (303), 303ra137-303ra137, 2015
3982015
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis
S Singh, A Sadanandam, KC Nannuru, ML Varney, R Mayer-Ezell, ...
Clinical Cancer Research 15 (7), 2380-2386, 2009
1782009
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S Singh, KC Nannuru, A Sadanandam, ML Varney, RK Singh
British journal of cancer 100 (10), 1638-1646, 2009
1442009
Matrix metalloproteinase (MMP)-13 regulates mammary tumor–induced osteolysis by activating MMP9 and transforming growth factor-β signaling at the tumor-bone interface
KC Nannuru, M Futakuchi, ML Varney, TM Vincent, EG Marcusson, ...
Cancer research 70 (9), 3494-3504, 2010
1412010
Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis
B Sharma, DM Nawandar, KC Nannuru, ML Varney, RK Singh
Molecular cancer therapeutics 12 (5), 799-808, 2013
1372013
Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κb Ligand
TJ Wilson, KC Nannuru, M Futakuchi, A Sadanandam, RK Singh
Cancer research 68 (14), 5803-5811, 2008
1042008
Cathepsin G-mediated enhanced TGF-β signaling promotes angiogenesis via upregulation of VEGF and MCP-1
TJ Wilson, KC Nannuru, M Futakuchi, RK Singh
Cancer letters 288 (2), 162-169, 2010
972010
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis
KC Nannuru, B Sharma, ML Varney, RK Singh
Journal of carcinogenesis 10, 2011
752011
Cathepsin G–mediated activation of pro–matrix metalloproteinase 9 at the tumor-bone Interface promotes transforming growth factor-β signaling and bone destruction
TJ Wilson, KC Nannuru, RK Singh
Molecular Cancer Research 7 (8), 1224-1233, 2009
742009
Small interfering RNA‐mediated CXCR1 or CXCR2 knock‐down inhibits melanoma tumor growth and invasion
S Singh, A Sadanandam, ML Varney, KC Nannuru, RK Singh
International journal of cancer 126 (2), 328-336, 2010
672010
Transforming growth factor‐β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation
M Futakuchi, KC Nannuru, ML Varney, A Sadanandam, K Nakao, K Asai, ...
Cancer science 100 (1), 71-81, 2009
672009
The expansion of heterotopic bone in fibrodysplasia ossificans progressiva is activin A‐dependent
J Upadhyay, LQ Xie, L Huang, N Das, RC Stewart, MC Lyon, K Palmer, ...
Journal of Bone and Mineral Research 32 (12), 2489-2499, 2017
562017
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
S Aykul, RA Corpina, EJ Goebel, CJ Cunanan, A Dimitriou, HJ Kim, ...
Elife 9, e54582, 2020
552020
Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1
TJ Wilson, KC Nannuru, RK Singh
Cancer Research 69 (7), 3188-3195, 2009
512009
Tumor-stromal interactions in bone metastasis
KC Nannuru, RK Singh
Current osteoporosis reports 8, 105-113, 2010
502010
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis
B Sharma, KC Nannuru, ML Varney, RK Singh
Clinical & experimental metastasis 32, 65-72, 2015
422015
In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse Model
NM Das, S Hatsell, K Nannuru, L Huang, X Wen, L Wang, LH Wang, ...
PLoS One 11 (2), e0150085, 2016
382016
Activin A does not drive post-traumatic heterotopic ossification
C Hwang, CA Pagani, N Das, S Marini, AK Huber, LQ Xie, J Jimenez, ...
Bone 138, 115473, 2020
272020
Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide
C Gonzaga-Jauregui, G Yesil, H Nistala, A Gezdirici, Y Bayram, ...
European Journal of Human Genetics 28 (9), 1243-1264, 2020
272020
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
S Aykul, L Huang, L Wang, NM Das, S Reisman, Y Ray, Q Zhang, ...
The Journal of Clinical Investigation 132 (12), 2022
242022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20